These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3122713)

  • 1. The effect of a serine proteinase inhibitor on DIC in septic abortion.
    Takeda S; Kume M; Takechi K; Kasamatsu T; Yoshida K; Kinoshita K; Mizuno M; Sakamoto S
    Asia Oceania J Obstet Gynaecol; 1987 Dec; 13(4):433-9. PubMed ID: 3122713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
    [No Abstract]   [Full Text] [Related]  

  • 3. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
    Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
    Taenaka N; Shimada Y; Kawai M; Yoshiya I; Kosaki G
    Anaesthesia; 1981 Apr; 36(4):389-93. PubMed ID: 6787945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
    Haemostasis; 1983; 13(4):262-7. PubMed ID: 6413308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects and therapy of disseminated intravascular coagulation].
    Lasch HG
    Hamatol Bluttransfus; 1970; 9():121-31. PubMed ID: 5508064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of the disseminated intravascular coagulation syndrome in septic shock].
    Makatsariia AD; Dobrovol'skiĭ VI
    Sov Med; 1981; (6):34-9. PubMed ID: 7280793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
    Wakui K; Takemae T; Kobayashi S
    No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic protease inhibitors for the treatment of DIC].
    Takahashi H
    Rinsho Byori; 2011 Feb; Suppl 147():152-8. PubMed ID: 21761764
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
    Taniguchi N; Kitani T; Kawagoe H; Horiuchi A; Masaoka T; Yasunaga K; Okamoto Y; Ohkubo A; Yonezawa T; Nagai K
    Rinsho Ketsueki; 1987 Oct; 28(10):1729-37. PubMed ID: 3133506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
    Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
    Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infected abortion and disseminated intravascular coagulation (DIC). Heparin prevention and early diagnosis of the DIC].
    Kuhn W; Graeff H
    Med Welt; 1971 Jul; 22(29):1199-200. PubMed ID: 5566152
    [No Abstract]   [Full Text] [Related]  

  • 16. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
    Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
    J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of DIC with a serine proteinase inhibitor.
    Yokota T; Yamada Y; Takahashi M; Kunii Y; Iwamoto K; Kagami M; Kikuchi S; Yamauchi H; Yoshikawa K
    Am J Emerg Med; 2001 Jul; 19(4):334-5. PubMed ID: 11447540
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Septic abortion and disseminated intravascular coagulation].
    Freitas F; Viçosa Júnior H; Kopstein J; Goldraich N
    Matern Infanc (Sao Paulo); 1974; 33(1):107-16. PubMed ID: 4456060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with the preventive use of heparin in septic abortion].
    Schwarz R
    Zentralbl Gynakol; 1978; 100(8):487-9. PubMed ID: 664971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.